• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
LGP
Click for more information
3.70% 8.4¢

LITTLE GREEN PHARMA LTD - News & Media

Market Cap $25.34M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Little Green Pharma (ASX:LGP) is an Australia-based medicinal cannabis company with a... Little Green Pharma (ASX:LGP) is an Australia-based medicinal cannabis company with a track record of sales growth with a clear pathway to increasing margins and driving revenues.More

Corporate Spotlight

Little Green Pharma (ASX:LGP) LGP is an Australia-based medicinal cannabis company with a track record of sales growth with a clear pathway to increasing margins and driving revenues.
View the full Corporate Spotlight arrow Created with Sketch.

LGP REPORTS REVENUE INCREASE IN Q4FY24

Articles & Videos

Little Green Pharma (ASX:LGP) reports revenue increase in Q4 FY24

This interview discusses Little Green Pharma’s (ASX:LGP) record-breaking quarterly results for June 2024, highlighting a 12% increase in revenue and significant cash receipts. CEO Paul Long elaborates on the company’s growth drivers, including new product sales in ...

24 Jul 2024 15:29 (AEST)

Little Green Pharma's cannabis sales leap 30%

Little Green Pharma saw sales leap 30% to $25.6 million in the financial year to March 31 witjh flower sales soaring 72% in Australia.

31 May 2024 16:58 (AEST)

Little Green Pharma closely eyeing USA's legal downgrade of Cannabis danger

Overnight, the Biden government did something sure to give their counterparts a stir – the USA downgraded the risk profile it gives cannabis.

02 May 2024 10:06 (AEST)

Little Green Pharma heading into Q2 cashed up after record sales

Little Green Pharma (ASX:LGP) wound up Q1CY24 with $5M in cash after posting record sales of $8.1M, up 53% QoQ.

17 Apr 2024 11:57 (AEST)

Little Green Pharma shares surge as Germany legalises Cannabis

Little Green Pharma (ASX: LGP), has revealed a groundbreaking development with the German Bundestag's decision on Friday to legalise cannabis, removing it from the Narcotics List starting April 1, 2024

26 Feb 2024 11:45 (AEDT)

Reset Mind Sciences to remain Little Green Pharma subsidiary

Reset Mind Sciences has withdrawn its offers under the Prospectus lodged with ASIC on November 9, 2023, and will remain a subsidiary of Little Green Pharma (ASX:LGP).

19 Feb 2024 12:11 (AEDT)

Little Green Pharma receives $5m R&D rebate

Little Green Pharma (ASX:LGP) has received a $5 million research and development (R&D) rebate, its largest to date.

01 Feb 2024 11:26 (AEDT)

Little Green Pharma's Cherry Co brand flourishes after December launch

Little Green Pharma (ASX:LGP) has released its quarterly activities report for December 2023, reporting a 25 per cent increase in revenue to $18.1 million.

31 Jan 2024 14:41 (AEDT)

Little Green Pharma kicks off WA psychedelic mental health trial

Little Green Pharma (ASX:LGP) attached entity Reset Mind Sciences has kicked off a WA-based trial investigating the use of psilocybin.

11 Jan 2024 11:03 (AEDT)

Little Green Pharma positions itself for growth in France's emerging medicinal cannabis market

Little Green Pharma (ASX:LGP) is primed for substantial growth after a major amendment to the French health security bill, paving the way for medicinal cannabis' integration into the national healthcare system.

07 Dec 2023 10:59 (AEDT)



(20min delay)
Last
8.4¢ 		Change
0.003(3.70%) 		Mkt cap ! $25.34M
Open High Low Value Volume
8.9¢ 8.9¢ 8.3¢ $10.77K 122.6K

Buyers (Bids)

No. Vol. Price($)
2 6790 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.9¢ 88825 1
View Market Depth
Last trade - 15.52pm 20/09/2024 (20 minute delay) ?
LGP (ASX) Chart

Top Stories

Harvey Norman hit with a second class action – and shareholders, once again, don't care

Harvey Norman (ASX:HVN) has confirmed it's been hit by a second class action this week over allegedly dodgy warranty cover – and the stock is up +1.23 at 11.15am Sydney time.
Week 38 Wrap: US markets panic at 50bp cut; ALS’s minerals revenue  slowdown; RBA path unclear Well, it finally happened – the US Fed cut interest rates this week, and we got a double dose: a whole -50bps knocked off.
Tennant Minerals clocks high-grade gold, copper hits at Bluebird in the NT Tennant Minerals has unveiled the results of its latest drill campaign at its Bluebird project, posting "high-grade" copper and gold hits.
ASX Market Open: Aussie stocks follow US surge after Fed rate cut decision | September 20, 2024 Australia's stock market is set to open higher today, following record performances on Wall Street, following the Federal Reserve's rate cut
Develop Global appoints GR to get Woodlawn copper-zinc plant online mid-2025 Develop shares jumped just over 4% in lunchtime trades on Friday as the company sees mid-2025 Woodlawn start.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.